155 related articles for article (PubMed ID: 37805139)
1. Arg177 and Asp159 from dog prion protein slow liquid-liquid phase separation and inhibit amyloid formation of human prion protein.
Li XN; Gao Y; Li Y; Yin JX; Yi CW; Yuan HY; Huang JJ; Wang LQ; Chen J; Liang Y
J Biol Chem; 2023 Nov; 299(11):105329. PubMed ID: 37805139
[TBL] [Abstract][Full Text] [Related]
2. The N-terminal domain of the prion protein is required and sufficient for liquid-liquid phase separation: A crucial role of the Aβ-binding domain.
Kamps J; Lin YH; Oliva R; Bader V; Winter R; Winklhofer KF; Tatzelt J
J Biol Chem; 2021 Jul; 297(1):100860. PubMed ID: 34102212
[TBL] [Abstract][Full Text] [Related]
3. Liquid-liquid phase separation of full-length prion protein initiates conformational conversion in vitro.
Tange H; Ishibashi D; Nakagaki T; Taguchi Y; Kamatari YO; Ozawa H; Nishida N
J Biol Chem; 2021; 296():100367. PubMed ID: 33545172
[TBL] [Abstract][Full Text] [Related]
4. Phase separation of the mammalian prion protein: Physiological and pathological perspectives.
do Amaral MJ; Freire MHO; Almeida MS; Pinheiro AS; Cordeiro Y
J Neurochem; 2023 Jul; 166(1):58-75. PubMed ID: 35149997
[TBL] [Abstract][Full Text] [Related]
5. Location of the cross-β structure in prion fibrils: A search by seeding and electron spin resonance spectroscopy.
Chu BK; Tsai RF; Hung CL; Kuo YH; Chen EH; Chiang YW; Chan SI; Chen RP
Protein Sci; 2022 Jun; 31(6):e4326. PubMed ID: 35634767
[TBL] [Abstract][Full Text] [Related]
6. Liquid-liquid phase separation and fibrillation of the prion protein modulated by a high-affinity DNA aptamer.
Matos CO; Passos YM; do Amaral MJ; Macedo B; Tempone MH; Bezerra OCL; Moraes MO; Almeida MS; Weber G; Missailidis S; Silva JL; Uversky VN; Pinheiro AS; Cordeiro Y
FASEB J; 2020 Jan; 34(1):365-385. PubMed ID: 31914616
[TBL] [Abstract][Full Text] [Related]
7. Impact of N-glycosylation site variants during human PrP aggregation and fibril nucleation.
Mishra R; Elgland M; Begum A; Fyrner T; Konradsson P; Nyström S; Hammarström P
Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):909-921. PubMed ID: 30935958
[TBL] [Abstract][Full Text] [Related]
8. Dissection of conformational conversion events during prion amyloid fibril formation using hydrogen exchange and mass spectrometry.
Singh J; Udgaonkar JB
J Mol Biol; 2013 Sep; 425(18):3510-21. PubMed ID: 23811055
[TBL] [Abstract][Full Text] [Related]
9. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic disorder and phase transitions: Pieces in the puzzling role of the prion protein in health and disease.
do Amaral MJ; Cordeiro Y
Prog Mol Biol Transl Sci; 2021; 183():1-43. PubMed ID: 34656326
[TBL] [Abstract][Full Text] [Related]
11. An intrinsically disordered pathological prion variant Y145Stop converts into self-seeding amyloids via liquid-liquid phase separation.
Agarwal A; Rai SK; Avni A; Mukhopadhyay S
Proc Natl Acad Sci U S A; 2021 Nov; 118(45):. PubMed ID: 34737230
[TBL] [Abstract][Full Text] [Related]
12. Structural Mechanism of Barriers to Interspecies Seeding Transmissibility of Full-Length Prion Protein Amyloid.
Ma T; Deng J; Ma S; Zhao W; Chang Z; Yu K; Yang J
Chembiochem; 2019 Nov; 20(21):2757-2766. PubMed ID: 31161647
[TBL] [Abstract][Full Text] [Related]
13. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
Lührs T; Zahn R; Wüthrich K
J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
[TBL] [Abstract][Full Text] [Related]
14. Different tau fibril types reduce prion level in chronically and de novo infected cells.
Celauro L; Burato A; Zattoni M; De Cecco E; Fantuz M; Cazzaniga FA; Bistaffa E; Moda F; Legname G
J Biol Chem; 2023 Aug; 299(8):105054. PubMed ID: 37454740
[TBL] [Abstract][Full Text] [Related]
15. N-terminal domain of prion protein directs its oligomeric association.
Trevitt CR; Hosszu LL; Batchelor M; Panico S; Terry C; Nicoll AJ; Risse E; Taylor WA; Sandberg MK; Al-Doujaily H; Linehan JM; Saibil HR; Scott DJ; Collinge J; Waltho JP; Clarke AR
J Biol Chem; 2014 Sep; 289(37):25497-508. PubMed ID: 25074940
[TBL] [Abstract][Full Text] [Related]
16. Self-Replication of Prion Protein Fragment 89-230 Amyloid Fibrils Accelerated by Prion Protein Fragment 107-143 Aggregates.
Sneideris T; Ziaunys M; Chu BK; Chen RP; Smirnovas V
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049945
[TBL] [Abstract][Full Text] [Related]
17. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
[TBL] [Abstract][Full Text] [Related]
18. Neutralizing Mutations Significantly Inhibit Amyloid Formation by Human Prion Protein and Decrease Its Cytotoxicity.
Huang JJ; Li XN; Liu WL; Yuan HY; Gao Y; Wang K; Tang B; Pang DW; Chen J; Liang Y
J Mol Biol; 2020 Feb; 432(4):828-844. PubMed ID: 31821812
[TBL] [Abstract][Full Text] [Related]
19. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
[TBL] [Abstract][Full Text] [Related]
20. A proposed mechanism for the promotion of prion conversion involving a strictly conserved tyrosine residue in the β2-α2 loop of PrPC.
Kurt TD; Jiang L; Bett C; Eisenberg D; Sigurdson CJ
J Biol Chem; 2014 Apr; 289(15):10660-10667. PubMed ID: 24596090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
